Carolinas Wealth Consulting’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-161
| Closed | -$7.13K | – | 1021 |
|
2023
Q3 | $7.13K | Hold |
161
| – | – | ﹤0.01% | 563 |
|
2023
Q2 | $6.61K | Hold |
161
| – | – | ﹤0.01% | 644 |
|
2023
Q1 | $5.75K | Sell |
161
-26
| -14% | -$929 | ﹤0.01% | 669 |
|
2022
Q4 | $7.06K | Hold |
187
| – | – | ﹤0.01% | 657 |
|
2022
Q3 | $8K | Hold |
187
| – | – | ﹤0.01% | 600 |
|
2022
Q2 | $7K | Hold |
187
| – | – | ﹤0.01% | 626 |
|
2022
Q1 | $7K | Hold |
187
| – | – | ﹤0.01% | 657 |
|
2021
Q4 | $6K | Sell |
187
-3,000
| -94% | -$96.3K | ﹤0.01% | 685 |
|
2021
Q3 | $107K | Hold |
3,187
| – | – | 0.02% | 235 |
|
2021
Q2 | $127K | Sell |
3,187
-5,000
| -61% | -$199K | 0.03% | 230 |
|
2021
Q1 | $368K | Sell |
8,187
-115
| -1% | -$5.17K | 0.09% | 108 |
|
2020
Q4 | $469K | Buy |
8,302
+5,187
| +167% | +$293K | 0.13% | 88 |
|
2020
Q3 | $148K | Buy |
3,115
+115
| +4% | +$5.46K | 0.05% | 155 |
|
2020
Q2 | $177K | Buy |
+3,000
| New | +$177K | 0.07% | 111 |
|